Found: 16
Select item for more details and to access through your institution.
Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 2, p. 294, doi. 10.1111/bjh.15074
- By:
- Publication type:
- Article
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1540, doi. 10.1002/ajh.27363
- By:
- Publication type:
- Article
Acute megakaryoblastic leukemia AML FAB-M7 in a patient 15 years after kidney transplantation.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00586
- By:
- Publication type:
- Article
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 148, doi. 10.1111/ejh.13523
- By:
- Publication type:
- Article
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 480, doi. 10.1007/s10637-010-9576-2
- By:
- Publication type:
- Article
Corrigendum to "OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT" [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S3-S4]
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 425, doi. 10.1016/j.clml.2022.03.010
- By:
- Publication type:
- Article
P-177: Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma: a multicohort analysis from phase III trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S133, doi. 10.1016/S2152-2650(21)02304-1
- By:
- Publication type:
- Article
OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S3, doi. 10.1016/S2152-2650(21)02079-6
- By:
- Publication type:
- Article
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00772-9
- By:
- Publication type:
- Article
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00434-2
- By:
- Publication type:
- Article
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 5, p. 649, doi. 10.1111/bjh.12198
- By:
- Publication type:
- Article
Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab.
- Published in:
- British Journal of Haematology, 2001, v. 112, n. 3, p. 820, doi. 10.1046/j.1365-2141.2001.02582.x
- By:
- Publication type:
- Article
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6431, doi. 10.3390/ijms25126431
- By:
- Publication type:
- Article